Basic symptom-modifying delayed-action drugs in therapy of osteoporosis
Glucosamine sulfate, or hydrochloride, and chondroitin sulfate are natural components of cartilaginous intercellular substance. In osteoarthrosis (OA), they exert a pronounced symptom-modifying effect and, when used long, they can also inhibit the X-ray progression of OA. The combination drugs that...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2011-09-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/372 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849339298260713472 |
|---|---|
| author | Vladimir Vasil'evich Badokin Vladimir Vasilievich Badokin |
| author_facet | Vladimir Vasil'evich Badokin Vladimir Vasilievich Badokin |
| author_sort | Vladimir Vasil'evich Badokin |
| collection | DOAJ |
| description | Glucosamine sulfate, or hydrochloride, and chondroitin sulfate are natural components of cartilaginous intercellular substance. In osteoarthrosis (OA), they exert a pronounced symptom-modifying effect and, when used long, they can also inhibit the X-ray progression of OA. The combination drugs that comprise glucosamine and chondroitin have some advantage over each component. These agents include teraflex. The efficacy of these pharmacological agents seems to be associated with their anti-inflammatory properties rather than with the stimulated synthesis of cartilaginous matrix. |
| format | Article |
| id | doaj-art-bb53198ddd0844d09a1b5ca53e18f511 |
| institution | Kabale University |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2011-09-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-bb53198ddd0844d09a1b5ca53e18f5112025-08-20T03:44:10ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2011-09-0153576310.14412/1996-7012-2011-6871677Basic symptom-modifying delayed-action drugs in therapy of osteoporosisVladimir Vasil'evich BadokinVladimir Vasilievich BadokinGlucosamine sulfate, or hydrochloride, and chondroitin sulfate are natural components of cartilaginous intercellular substance. In osteoarthrosis (OA), they exert a pronounced symptom-modifying effect and, when used long, they can also inhibit the X-ray progression of OA. The combination drugs that comprise glucosamine and chondroitin have some advantage over each component. These agents include teraflex. The efficacy of these pharmacological agents seems to be associated with their anti-inflammatory properties rather than with the stimulated synthesis of cartilaginous matrix.https://mrj.ima-press.net/mrj/article/view/372osteoarthrosischondroitin sulfateglucosamine sulfateteraflex |
| spellingShingle | Vladimir Vasil'evich Badokin Vladimir Vasilievich Badokin Basic symptom-modifying delayed-action drugs in therapy of osteoporosis Современная ревматология osteoarthrosis chondroitin sulfate glucosamine sulfate teraflex |
| title | Basic symptom-modifying delayed-action drugs in therapy of osteoporosis |
| title_full | Basic symptom-modifying delayed-action drugs in therapy of osteoporosis |
| title_fullStr | Basic symptom-modifying delayed-action drugs in therapy of osteoporosis |
| title_full_unstemmed | Basic symptom-modifying delayed-action drugs in therapy of osteoporosis |
| title_short | Basic symptom-modifying delayed-action drugs in therapy of osteoporosis |
| title_sort | basic symptom modifying delayed action drugs in therapy of osteoporosis |
| topic | osteoarthrosis chondroitin sulfate glucosamine sulfate teraflex |
| url | https://mrj.ima-press.net/mrj/article/view/372 |
| work_keys_str_mv | AT vladimirvasilevichbadokin basicsymptommodifyingdelayedactiondrugsintherapyofosteoporosis AT vladimirvasilievichbadokin basicsymptommodifyingdelayedactiondrugsintherapyofosteoporosis |